n-cyclopropyl adenosine-5'-carboxamide has been researched along with su 6656 in 1 studies
Studies (n-cyclopropyl adenosine-5'-carboxamide) | Trials (n-cyclopropyl adenosine-5'-carboxamide) | Recent Studies (post-2010) (n-cyclopropyl adenosine-5'-carboxamide) | Studies (su 6656) | Trials (su 6656) | Recent Studies (post-2010) (su 6656) |
---|---|---|---|---|---|
14 | 0 | 5 | 154 | 0 | 73 |
Protein | Taxonomy | n-cyclopropyl adenosine-5'-carboxamide (IC50) | su 6656 (IC50) |
---|---|---|---|
Proto-oncogene tyrosine-protein kinase Src | Gallus gallus (chicken) | 0.1 | |
Proto-oncogene tyrosine-protein kinase LCK | Mus musculus (house mouse) | 0.15 | |
Tyrosine-protein kinase Fyn | Homo sapiens (human) | 0.17 | |
Tyrosine-protein kinase Yes | Homo sapiens (human) | 0.02 | |
Tyrosine-protein kinase Lyn | Homo sapiens (human) | 0.13 | |
Proto-oncogene tyrosine-protein kinase receptor Ret | Homo sapiens (human) | 0.77 | |
Proto-oncogene tyrosine-protein kinase Src | Homo sapiens (human) | 0.1765 | |
Receptor-type tyrosine-protein kinase FLT3 | Homo sapiens (human) | 8.7 | |
Serine/threonine-protein kinase 3 | Homo sapiens (human) | 0.11 | |
Serine/threonine-protein kinase BRSK2 | Homo sapiens (human) | 0.1 | |
Aurora kinase B | Homo sapiens (human) | 0.019 | |
ALK tyrosine kinase receptor | Homo sapiens (human) | 0.85 | |
Aurora kinase C | Homo sapiens (human) | 0.017 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
1 other study(ies) available for n-cyclopropyl adenosine-5'-carboxamide and su 6656
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |